Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
Thistlethwaite
J R
JR
Department of Surgery, University of Chicago, Illinois.
Woodle
E S
ES
Mayes
J T
JT
Stuart
J K
JK
Heffron
T G
TG
Spargo
B H
BH
Stuart
F P
FP
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle / Q000379:methods*; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone